Methods and compositions for treating 5alpha-reductase type 1 and type 2 dependent conditions

• 收藏
• 分享

专利权人:

Dyad Pharmaceutical Corporation

发明人:

Nigra, Thomas P.,Hoke, Glenn D.

申请号：

AU2004285134

公开号：

AU2004285134B2

申请日:

2004.10.20

申请国别(地区):

AU

年份:

2012

代理人:

摘要：

The invention relates generally to the use of anti-sense oligonucleotides, small interfereing RNA, and ribozymes to modulate expression of the human steroid 5α-­reductase gene and thereby modulate levels of dihydrotestosterone (DHT). Elevated levels of DHT are associated with various disorders including, but not limited to, skin diseases, hair loss, hirsuitism, and benign prostatic hyperplasia. The invention specifically relates to formulations of these anti-sense oligonucleotides, small interfering RNA, and ribozymes for administration to treat and prevent disorders.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/